Drug intelligence / Profile preview

Hypertonic saline + epinephrine

Development stage
Unknown
Modality
Small Molecules
Administration
Inhalation, Local Injection
01

Overview

Hypertonic saline + epinephrine is a combination therapy consisting of a concentrated sodium chloride solution (typically 3% or higher) and the adrenergic agonist epinephrine. This combination is used in two main clinical contexts: - As a nebulized treatment for acute moderate bronchiolitis in infants, where it has been shown to reduce hospital stay and improve clinical severity scores compared to hypertonic saline alone[1][4][5][6]. - As an endoscopic local injection for hemostasis in upper gastrointestinal bleeding, where the mixture (commonly 3.6% or 7.1% sodium chloride with 0.005% epinephrine) is injected around bleeding vessels to arrest hemorrhage, particularly from gastric and duodenal ulcers[2]. Mechanistically, hypertonic saline acts osmotically to draw fluid out of edematous airway tissues or mucosa, while epinephrine stimulates alpha-adrenergic receptors causing vasoconstriction (reducing edema and bleeding), as well as beta-adrenergic receptors leading to bronchodilation[8]. The combination leverages both the physical effects of osmotic dehydration and the pharmacological effects of adrenergic stimulation.

Other names
hypertonic saline-epinephrine solutionHS + epinephrine
02

Targets

AR (Adrenergic receptors)

Beyond the preview

Go deeper on Hypertonic saline + epinephrine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hypertonic saline + epinephrine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call